Scott Barnes - May 21, 2021 Form 4 Insider Report for STAAR SURGICAL CO (STAA)

Role
Chief Medical Officer
Signature
/s/ Samuel Gesten as attorney-in-fact for Scott Barnes
Stock symbol
STAA
Transactions as of
May 21, 2021
Transactions value $
-$1,220,918
Form type
4
Date filed
5/21/2021, 04:05 PM
Next filing
Mar 8, 2022

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction STAA Common Stock Options Exercise $40.4K +2.5K +10.72% $16.15 25.8K May 21, 2021 Direct
transaction STAA Common Stock Options Exercise $80.2K +2.23K +8.63% $35.98 28.1K May 21, 2021 Direct
transaction STAA Common Stock Options Exercise $208K +7.57K +26.97% $27.53 35.6K May 21, 2021 Direct
transaction STAA Common Stock Disposed to Issuer -$1.55M -12.3K -34.52% $126.05 23.3K May 21, 2021 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction STAA Common Stock Options Options Exercise $0 -2.5K -32.47% $0.00 5.2K May 21, 2021 Common Stock 2.5K $16.15 Direct
transaction STAA Common Stock Options Options Exercise $0 -2.23K -19.58% $0.00 9.16K May 21, 2021 Common Stock 2.23K $35.98 Direct F2
transaction STAA Common Stock Options Options Exercise $0 -7.57K -38.89% $0.00 11.9K May 21, 2021 Common Stock 7.57K $27.53 Direct F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $126.00 to $126.36, inclusive.
F2 The options granted become exercisable as follows: 1/3 on 3/14/2020 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/14/2022.
F3 The options granted become exercisable as follows: 1/3 on 3/20/2021 and the remaining 2/3 of such options shall become exercisable over the following 24 months in equal amounts on a monthly basis. In the event the options do not evenly divide into 24 months, the remaining balance of options granted shall become exercisable on 3/20/2023.